Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA.
J Natl Cancer Inst. 2019 Jan 1;111(1):60-68. doi: 10.1093/jnci/djy071.
Ovarian Mesonephric-Like Adenocarcinoma Arising Within a Serous Borderline Tumor: Insights into the Implications of Cell Origin-A Case Report and Review of the Literature.
Chang R, Huang L, Chen H.
Int J Surg Pathol. 2025 Oct;33(7):1644-1648. doi: 10.1177/10668969251331186. Epub 2025 Apr 4.
Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen Y, Wang J, Liu Y, Chen P, Wu X, Wen J.
Oncol Rep. 2015 Jun;33(6):2915-23. doi: 10.3892/or.2015.3937. Epub 2015 Apr 28.
High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment.
Vivod G, Merlo S, Kovacevic N.
Curr Oncol. 2024 Apr 2;31(4):1920-1935. doi: 10.3390/curroncol31040144.
Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of the Literature.
Maharjan D, Collins K, Hou T, Umphress B, Robertson SE, Segura S.
Int J Gynecol Pathol. 2025 Mar 1;44(2):193-197. doi: 10.1097/PGP.0000000000001070. Epub 2024 Sep 10.
Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance.
Li Q, Li W, Wang J, Shi W, Wang T.
J Obstet Gynaecol. 2024 Dec;44(1):2361862. doi: 10.1080/01443615.2024.2361862. Epub 2024 Jun 25.
Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG, Vosmikova H, Laco J.
Int J Gynecol Pathol. 2020 Jan;39(1):84-92. doi: 10.1097/PGP.0000000000000573.
Personalized Medicine for Primary Treatment of Serous Ovarian Cancer.
Longo DL.
N Engl J Med. 2019 Dec 19;381(25):2471-2474. doi: 10.1056/NEJMe1914488.
Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
Choi KH, Kim H, Bae GE, Lee SH, Woo HY, Kim HS.
Anticancer Res. 2021 Sep;41(9):4587-4601. doi: 10.21873/anticanres.15272.
ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M, Saito T, Sato N.
PLoS One. 2013 Jun 6;8(6):e65158. doi: 10.1371/journal.pone.0065158. Print 2013.
